Patient Cost and Assistance Programs

OPTIONS TO HELP ELIGIBLE PATIENTS WITH ACCESS TO XELJANZ®/XELJANZ® XR (tofacitinib) AFTER A PRESCRIBING DECISION HAS BEEN MADE
Commercial Insurance
  • Co-Pay Savings Program*—Eligible patients may be able to reduce out-of-pocket costs, with a maximum benefit of $15,000 per calendar year
Additional offers for eligible, commercially insured patients by request
  • Interim Care Rx—Up to 6 months of free XELJANZ XR or XELJANZ shipped to eligible patients during a delay in prior authorization or appeal
Government-Funded Insurance
  • Locating alternative funding sources
    For those patients who need help with their medication cost-sharing requirements, Pfizer will refer patients who appear to be eligible to Medicaid
  • Pfizer Patient Assistance Program
    Free XELJANZ XR or XELJANZ shipped directly to eligible, underinsured patients
No Insurance Coverage
  • Locating alternative funding sources
    For those patients who need help with their medication cost-sharing requirements, Pfizer will refer patients who appear to be eligible to Medicaid
  • Pfizer Patient Assistance Program
    Eligible patients may receive XELJANZ XR or XELJANZ at no charge
*Administered by TrialCard. Availability subject to patient eligibility requirements and/or applicable limits, terms, and conditions. See Terms & Conditions.
The free product for this program is for certain commercially insured patients only. Not available to residents in the states of MA, IA, MN, MO, OH, or RI. See Terms & Conditions.
Free medicines from Pfizer are provided through the Pfizer Patient Assistance FoundationTM. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc, with distinct legal restrictions.
JAK=Janus kinase; RA=rheumatoid arthritis; Rx=prescription.